NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
test
评论:
updating today
评论:
The terminal corrective point for CTXR is this month. The max drawdown is about -30% from here if we fell more, which would be a blessing...since the upside is $5+ or about +462% from here. Accumulate accumulate accumulate
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。